Latest news and articles about Regeneron
Total: 1 articles found
The U.S. government’s announcement of a 100% tariff on imported drugs is essentially a tactical negotiation tool rather than a fiscal reality. Through a series of 'Most Favored Nation' deals and manufacturing incentives, the administration is using the threat of high tariffs to force global drugmakers into domestic investment and lower pricing.
